Jae-Youn Kim

Title: Innovations of Jae-Youn Kim in Thrombopoietin Protein Variants

Introduction

Jae-Youn Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of protein variants that have important biological functions. His work has implications for medical treatments and pharmaceutical applications.

Latest Patents

Jae-Youn Kim holds a patent for "Thrombopoietin protein variants." This invention discloses a protein variant that substitutes valine for phenylalanine residue in a binding domain, which has a biological response-modifying function by binding to a receptor, ligand, or substrate. The patent also includes a DNA sequence encoding the protein variant, a recombinant expression vector linked to the DNA, and a host cell that has been transformed or transfected with the vector. Furthermore, the invention outlines a method for preparing the protein variant by cultivating the host cell and isolating the protein from the resulting culture. Additionally, it presents a pharmaceutical composition that includes the protein variant and a pharmaceutically acceptable carrier.

Career Highlights

Jae-Youn Kim is associated with Medexgen Co., Ltd., where he continues to advance his research and development efforts. His work at the company reflects his commitment to innovation in the biotechnology sector.

Collaborations

He has collaborated with notable colleagues, including Yong-Hoon Chung and Hak-sup Lee, who contribute to the research and development initiatives within the company.

Conclusion

Jae-Youn Kim's innovative work in thrombopoietin protein variants showcases his expertise and dedication to advancing biotechnology. His contributions have the potential to impact medical treatments significantly.